Realizing Outperformance

Downloads

Fact Sheet
Prospectus
Supplement to Prospectus – Aescap Life Sciences
Explanation Supplement to Prospectus – Aescap Life Sciences
Supplement II to Prospectus – Aescap Life Sciences
Explanation Supplement II to Prospectus – Aescap Life Sciences
Subscription Form
Additional Subscription Form
Self-certification form individuals (FATCA)
Self-certification form entities (FATCA)
Redemption form
Statement regarding Sustainable Finance Disclosure Regulation
ESG Charter Aescap Life Sciences March 10 2021

Documents Fund Manager

Extract Chamber of Commerce
Copy of Investment Management licence
Confirmation Privium FM Status AIFM
Remuneration Policy Privium Fund Management B.V.
Statement regarding Principal Adverse Impacts
Integration of sustainability risks

Financial Reports Fund Manager

Semi-Annual Report 2020
Annual Report 2019
Semi-Annual Report 2019
Annual Report 2018
Semi-Annual Report 2018
Annual Report 2017
Semi-Annual Report 2017
Annual Report 2016
Semi-Annual Report 2016
Annual Report 2015
Semi-Annual Report 2015
Annual Report 2014
Annual Report 2013
Annual Report 2012

Key Investor Document / Essentiële Beleggersinformatie

KID – Investors Unit Class
KID – Investors €10M+ Unit Class
KID – Investors €20M+ Unit Class
KID – Investors €30M+ Unit Class
KID – Investors UK Unit Class
KID – Investors <500k Unit Class
KID – Investors Manager Unit Class
Essentiële Beleggersinformatie

Financial Reports Aescap Life Sciences

Semi-Annual Report 2020
Annual Report 2019
Semi-Annual Report 2019
Annual Report 2018
Annual Report 2017/2016 (Extended Bookyear)